Combination therapy for the treatment of diabetes and obesity
US5908830A · kind A · utility
69Cited by
10References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 1997 |
| Grant date | Jun 1, 1999 |
| Priority date | — |
| Expiry date | Oct 30, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2264
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The combination of a metabolic rate modifying agent (e.g., a .beta..sub.3 adrenergic receptor agonist) and a feeding behavior modifying agent (e.g., a NPY5 antagonist) is useful in the treatment of obesity and diabetes, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients. Methods of treating obesity and diabetes are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.